gabexate has been researched along with Infections, Staphylococcal Skin in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ju, Y | 1 |
| He, L | 1 |
| Zhou, Y | 1 |
| Yang, T | 1 |
| Sun, K | 1 |
| Song, R | 1 |
| Yang, Y | 1 |
| Li, C | 1 |
| Sang, Z | 1 |
| Bao, R | 1 |
| Luo, Y | 1 |
1 other study available for gabexate and Infections, Staphylococcal Skin
| Article | Year |
|---|---|
Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Boron Compounds; Boronic Acids; Endopeptidase Cl | 2020 |